Tanis I share your sentiments re. him. I'm not su
Post# of 30067
Posted On: 03/02/2015 9:01:22 AM
Tanis I share your sentiments re. him. I'm not sure what happened either, but his great talent for market savy and DD have been completely shrouded by his obsession to bash AMBS and especially Gerald. Hopefully he will reconsider his negative slant and become more positive as the AMBS story continues to unfold.
I too am expecting some substantive news some time early this week to explain the explosive buying Friday. So many catalysts in the fire that anyone of them could be the spark to ignite the powder keg that is AMBS. I am expecting news regarding a grant in regards to ESS-W, Eltroprizine, or perhaps even LYMPRO from any number of sources, but we know that the DOD has been actively funding ESS-W in the past; MJFF has actively helped fund Eltoprizine's Phase studies; and then you've got LYMPRO's possible conncections with AA and NIH and others, in addition to MSPrecise and possibilities there.
I truly believe Friday's explosive buying may simply be that in the mind of investors, AMBS's pipeline has reached "critical mass" and that in the mind of many, it has become extremely unlikely that there will not be either significant revenues from LYMPRO or funding commitments from possible multiple sources. I believe this month could be the breakout facet we've been waiting for!
I too am expecting some substantive news some time early this week to explain the explosive buying Friday. So many catalysts in the fire that anyone of them could be the spark to ignite the powder keg that is AMBS. I am expecting news regarding a grant in regards to ESS-W, Eltroprizine, or perhaps even LYMPRO from any number of sources, but we know that the DOD has been actively funding ESS-W in the past; MJFF has actively helped fund Eltoprizine's Phase studies; and then you've got LYMPRO's possible conncections with AA and NIH and others, in addition to MSPrecise and possibilities there.
I truly believe Friday's explosive buying may simply be that in the mind of investors, AMBS's pipeline has reached "critical mass" and that in the mind of many, it has become extremely unlikely that there will not be either significant revenues from LYMPRO or funding commitments from possible multiple sources. I believe this month could be the breakout facet we've been waiting for!
(0)
(0)